Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis

Phytotherapy Research

Volumn 29, Issue 3, 2015, Pages 357-365

  Guo, Li Da ^a,b   Shen, Yong Qing ^b,c   Zhao, Xiao Han ^c   Guo, Li Jian ^a   Yu, Zhi Jun ^b   Wang, Duo ^b   Liu, Li Meng ^b   Liu, Jing Ze ^b  

^a HEBEI COLLEGE OF INDUSTRY AND TECHNOLOGY   (China)

^b HEBEI NORMAL UNIVERSITY   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; colorectal carcinoma; curcumin; immunodeficient mice; in vivo; oxaliplatin

Indexed keywords

CASPASE 3; CURCUMIN; CYCLOPHOSPHAMIDE; HEAT SHOCK PROTEIN 70; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXALIPLATIN; PROCASPASE 3; PROPOLY(ADENOSINE DIPHOSPHATE RIBOSE)POLYMERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN PRECURSOR; SURVIVIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; PLATINUM COMPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CELL ULTRASTRUCTURE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; G2 PHASE CELL CYCLE CHECKPOINT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LOVO CELL LINE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; S PHASE CELL CYCLE CHECKPOINT; TREATMENT DURATION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; CELL CYCLE CHECKPOINT; COLORECTAL NEOPLASMS; DRUG COMBINATION; DRUG EFFECTS; DRUG POTENTIATION; DRUG SCREENING; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

MUS; MUS MUSCULUS;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CURCUMIN; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MALE; MICE; MICE, NUDE; ORGANOPLATINUM COMPOUNDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84924287910     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5257     Document Type: Article

References (41)

1. Aggarwal S, Ichikawa H, Takada Y, Sandur, SK, Shishodia S, Aggarwal BB,. 2006. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69: 195-206.
2. Chadalapaka G, Jutooru I, Chintharlapalli S, et al,. 2008. Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 68: 5345-5354.
3. Chen A, Xu J, Johnson AC,. 2006. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25: 278-287.
4. Chresta CM, Masters JR, Hickman JA,. 1996. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res 56: 1834-1841.
5. Dixon SC, Soriano BJ, Lush RM, Borner MM, Figg WD,. 1997. Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. Ann Pharmacother 31: 76-82.
6. Feldmann G, Dhara S, Fendrich V, et al,. 2007. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67: 2187-2196.
7. Feldmann G, Fendrich V, McGovern K, et al,. 2008. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol Cancer Ther 7: 2725-2735.
8. Fischel JL, Rostagno P, Formento P, Dubreuil A, Etienne MC, Milano G,. 2001. Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines. Br J Cancer 84: 579-585.
9. Garrido C, Gurbuxani S, Ravagnan L, Kroemer G,. 2001. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 286: 433-442.
10. Giri B, Gomes A, Sengupta R, et al,. 2009. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells. Anticancer Res 29: 395-401.
11. Guo LD, Chen XJ, Hu YH, Yu ZJ, Wang D, Liu JZ,. 2013. Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother Res 27: 422-430.
12. Huang MT, Smart RC, Wong CQ, Conney AH,. 1988. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48: 5941-5946.
13. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH,. 1994. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54: 5841-5847.
14. Igney FH, Krammer PH,. 2002. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2: 277-288.
15. Jemal A, Center MM, Ward E, Thun MJ,. 2009. Cancer occurrence. Methods Mol Biol 471: 3-29.
16. Johnson VL, Ko SC, Holmstrom TH, Eriksson JE, Chow SC,. 2000. Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis. J Cell Sci 113: 2941-2953.
17. Kelloff GJ, Crowell JA, Steele VE, et al,. 2000. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 130: 467S-471S.
18. Khor TO, Keum YS, Lin W, et al,. 2006. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res 66: 613-621.
19. Kuebler JP, Wieand HS, O'Connell MJ, et al,. 2007. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 25: 2198-2204.
20. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB,. 2007. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67: 3853-3861.
21. Lev-Ari S, Strier L, Kazanov D, et al,. 2005. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 11: 6738-6744.
22. Li F, Brattain MG,. 2006. Role of the survivin gene in pathophysiology. Am J Pathol 169: 1-11.
23. Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R,. 2004. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 101: 2351-2362.
24. Lin HP, Kuo LK, Chuu CP,. 2012. Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells. Phytother Res 26: 122-126.
25. Louvet C, Coudray AM, Tournigand C, et al,. 2000. Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice. Anti Cancer Drugs 11: 579-582.
26. Martin RC, Aiyer HS, Malik D, Li Y,. 2012. Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: similar root but different effects. Food Chem Toxicol 50: 227-231.
27. Meesarapee B, Thampithak A, Jaisin Y, et al,. 2014. Curcumin I mediates neuroprotective effect through attenuation of quinoprotein formation, p-p38 MAPK expression, and caspase-3 activation in 6-hydroxydopamine treated SH-SY5Y cells. Phytother Res 28: 611-616.
28. Mushiake H, Tsunoda T, Nukatsuka M, Shimao K, Fukushima M, Tahara H,. 2005. Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo. Cancer Immunol Immunother 54: 120-128.
29. Nautiyal J, Banerjee S, Kanwar SS, et al,. 2011. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. Int J Cancer 128: 951-961.
30. Newman DJ, Cragg GM,. 2007. Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477.
31. Odot J, Albert P, Carlier A, Tarpin M, Devy J, Madoulet C,. 2004. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int J Cancer 111: 381-387.
32. Patel BB, Sengupta R, Qazi S, et al,. 2008. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int J Cancer 122: 267-273.
33. Pestieau SR, Belliveau JF, Griffin H, Stuart OA, Sugarbaker PH,. 2001. Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies. J Sur Oncol 76: 106-114.
34. Rashmi R, Santhosh Kumar TR, Karunagaran D,. 2003. Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett 538: 19-24.
35. Sharma RA, Gescher AJ, Steward WP,. 2005. Curcumin: the story so far. Eur J Cancer 41: 1955-1968.
36. Shishodia S, Chaturvedi MM, Aggarwal BB,. 2007. Role of curcumin in cancer therapy. Curr Probl Cancer 31: 243-305.
37. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP,. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31: 1-9.
38. Wang JB, Qi LL, Zheng SD, Wu TX,. 2009. Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J Zhejiang Univ Sci B 10: 93-102.
39. Xu G, Ren G, Xu X, et al,. 2010. Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colon carcinogenesis. Food Chem Toxicol 48: 390-395.
40. Xu JM, Azzariti A, Colucci G, Paradiso A,. 2003. The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines. Cancer Chemother Pharmacol 52: 442-448.
41. Yamauchi Y, Izumi Y, Yamamoto J, Nomori H,. 2014. Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells. Phytothery Res 28: 728-735.